Dynamics of prescription drug use, diagnoses and health care utilization after community managed SARS-CoV-2 infection

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/41235
• EU PAS number:
  EUPAS37658
• Study ID:
  41235
• Official title and acronym:
  Dynamics of prescription drug use, diagnoses and health care utilization after community managed SARS-CoV-2 infection
• DARWIN EU® study:
  No
• Study countries:
  Denmark
• Study description:
  Using the Danish national health registries, we examine drug use, hospital diagnoses and health care utilization prior to and after SARS-CoV-2 infection among individuals with community managed SARS-CoV-2 infection. Analyses are repeated for an age and sex matched cohort of individuals tested negative for SARS-CoV-2 and individuals hospitalized with SARS-CoV-2 infection.
• Study status:
  Finalised

Research institution and networks

Institutions

Pharmacoepi center, University of Southern Denmark

Denmark

Contact details

Anton Pottegård

Study contact

[e-mail]

Anton Pottegård

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned: 01/10/2020

Actual: 01/10/2020

Data collection

Planned: 27/02/2020

Actual: 27/02/2020

Start date of data analysis

Planned: 20/10/2020

Actual: 20/10/2020

Date of final study report

Planned: 15/11/2020

Actual: 10/05/2021

Sources of funding

Other

More details on funding

University of Southern Denmark

Study protocol

Initial protocol

EUPAS37658_protocol initial

Updated protocol

protocol-eu-pas-amended3

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable